STAT

To lower costs, Massachusetts seeks to limit Medicaid drug coverage

State officials argued to CMS that they should be able to use some of the same tools that commercial insurers employ to contain costs.

Alarmed by rising prescription drug prices, Massachusetts officials are seeking permission from the federal government to limit the number of medicines that would be covered by the state Medicaid program, which is currently required to provide coverage for all treatments.

In making their request, state officials argue they should be able to use some of the same tools that commercial insurers employ to contain costs. And they insist such a move is needed in order to preserve the larger mission of providing adequate health coverage.

“Since 2010, MassHealth drug spending has risen at a to the U.S. Center for Medicare & Medicaid Services. MassHealth is the state’s Medicaid program.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Wegovy Insurance Coverage, Zepbound Shortages, And More
The first major U.S. health insurers have agreed to start paying for the Wegovy weight loss drug for certain people on Medicare with heart conditions.
STAT1 min read
Opinion: HHS’s Proposed Rule Pays Lip Service To Addressing The Climate Crisis, The Greatest Threat To Human Health
HHS's proposal for addressing the climate crisis serves as an example of what historian and philosopher Hannah Arendt defined as the "banality of evil."
STAT1 min read
STAT+: Pharmalittle: We’re Watching A Ban Of Compounded Versions Of GLP-1s, A Biogen Acquisition, And More
Good morning from San Diego. This is Jonathan Wosen, West Coast biotech and life sciences reporter, filling in for Ed Silverman while he’s away from the Pharmalittle campus. I’m not a coffee drinker, but who needs caffeine when you’ve got the raw adr

Related Books & Audiobooks